Ventyx Biosciences (VTYX)

New Form 8-K - Ventyx Biosciences, Inc. Filed: 2025-06-17 AccNo: 0000950170-25-087068 Size: 275 KB Item 7.01: Regulation FD Disclosure Item 8.01: Other Events Item 9.01: Financial Statements and Exhibits

OncoCyte Corporation (OCX)

New Form 8-K - Oncocyte Corp Filed: 2025-06-17 AccNo: 0001641172-25-015338 Size: 507 KB Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year Item 7.01: Regulation FD Disclosure Item 9.01: Financial Statements and Exhibits

Dynavax Technologies Corporation (DVAX)

New Form 8-K - DYNAVAX TECHNOLOGIES CORP Filed: 2025-06-17 AccNo: 0001193125-25-141755 Size: 383 KB Item 3.03: Material Modifications to Rights of Security Holders Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year Item 5.07: Submission of Matters to a Vote of Security Holders Item 9.01: Financial …

Verve Therapeutics (VERV)

New Form 8-K - Verve Therapeutics, Inc. Filed: 2025-06-17 AccNo: 0001193125-25-141748 Size: 1 MB Item 1.01: Entry into a Material Definitive Agreement Item 8.01: Other Events Item 9.01: Financial Statements and Exhibits

Mineralys Therapeutics Inc (MLYS)

New Form 8-K - Mineralys Therapeutics, Inc. Filed: 2025-06-17 AccNo: 0001933414-25-000070 Size: 223 KB Item 7.01: Regulation FD Disclosure Item 8.01: Other Events Item 9.01: Financial Statements and Exhibits

Dyne Therapeutics Inc (DYN)

New Form 8-K - Dyne Therapeutics, Inc. Filed: 2025-06-17 AccNo: 0001193125-25-141739 Size: 3 MB Item 7.01: Regulation FD Disclosure Item 8.01: Other Events Item 9.01: Financial Statements and Exhibits